Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¿¹ÈÄ°¡ ÁÁÀº Á¶Á÷ÇÐÀû À¯ÇüÀÇ À¯¹æ¾Ï -¼öÁú¾Ï, Á¡¾×»ó¾Ï, À¯µÎ»ó¾Ï ¹× °ü»ó¾ÏÀÇ ÀÓ»óÀû °íÂû- Clinical Analysis of the Favorable Type of Breast Cancer -Medullary, Mucinous, Papillary and Tubular Carcinoma-

´ëÇѾÏÇÐȸÁö 1999³â 31±Ç 1È£ p.82 ~ 89
¼Ò¼Ó »ó¼¼Á¤º¸
Àüâ¿Ï/Chang Wan Jeon ³ë¿ìö/¹®³­¸ð/¹é³²¼±/ÀÌÁ¾ÀÎ/ÃÖµ¿¿í/¹æÈ£À±/Woo Chul Noh/Nan Mo Moon/Nam Sun Paik/Jong Inn Lee/Dong Wook Choi/Ho Yoon Bang

Abstract

¼­·Ð
ÀϹÝÀûÀΠħÀ±¼º À¯¹æ¾Ï¿¡ ºñÇÏ¿© ÁÁÀº ¿¹Èĸ¦ º¸ÀÌ´Â °ÍÀ¸·Î ¾Ë·ÁÁ®, Á¶Á÷ÇÐÀû ºÐ·ù»ó
¿¹ÈÄ°¡ ÁÁÀº À¯Çü(favorable type)À¸·Î ºÐ·ùµÇ´Â ¼öÁú¾Ï(medullary carcinoma), Á¡¾×»ó¾Ï
(mucinous carcinoma), À¯µÎ»ó¾Ï(papillary carcinoma), °ü»ó¾Ï(tubular carcinoma)Àº ÈçÇÏÁö
¾ÊÀº ¾ÏÁ¾À¸·Î Àüü À¯¹æ¾ÏÀÇ °¢°¢ 2.0¡­8.0%(1,8¡­12), 1.0¡­2.0%(13), 0.3¡­3.0%(14), 2.0%
ÀÌÇϸ¦ Â÷ÁöÇÑ´Ù. ¿ì¸®³ª¶óÀÇ °æ¿ì ÃæºÐÇÑ Áõ·Ê¼ö¸¦ Æ÷ÇÔÇÑ À̵é Á¾¾ç¿¡ ´ëÇÑ Àå±âÃßÀû°á°ú
´Â °ÅÀÇ ¾ø´Â ½ÇÁ¤ÀÌ´Ù. µû¶ó¼­ ÀúÀÚµéÀº 1987³â 1¿ùºÎÅÍ 1997³â 12¿ù±îÁö ¸¸11³â°£ ¿øÀÚ·Â
º´¿ø ¿Ü°ú¿¡¼­ Ä¡·áÇÑ À¯¹æ¾Ï ȯÀÚ 2,961¸í Áß Á¶Á÷ÇÐÀûÀû ºÐ·ù»ó ¿¹ÈÄ°¡ ÁÁÀº À¯ÇüÀ¸·Î ±¸
ºÐµÇ´Â ¼öÁú¾Ï, Á¡¾×»ó¾Ï, À¯µÎ»ó¾Ï, °ü»ó¾ÏÀ¸·Î Áø´Ü¹Þ°í Ä¡·áÇÑ 83¿¹¿¡ ´ëÇÑ ÀÓ»ó ºÐ¼®À»
½ÃÇàÇÏ¿© °á°ú¸¦ ¹®Çå °íÂû°ú ÇÔ²² º¸°íÇÏ´Â ¹ÙÀÌ´Ù.

Purpose: The favorable types of the breast cancer - medullary, mucinous, papillary
and tubular carcinoma are uncommon subtypes and their incidences in different series
ranges between 2.0% and 8.0%, 1% and 2%, 0.3% and 3%, less than 2% of all breast
cancers, respectively. In western countries these subtypes have been reported to have
good prognosis and slow growth rate. Clinically, these tumors have lower frequency of
axillary nodal involvement and better 5-year or 10-year surviral rate than the other
common types of breast cancer.
Materials and Methods: To determine the clinical charactcristics and to evaluate the
correlation between the progrostic factors and survival rate of these tumors, the medical
records of 83 women with medullary, mucinous, papillary and tubular carcinoma treated
at Korea Cancer Center Hospital between Jan. 1987 and Dec. 1997 were reviewed
retrospectively.
Results: The incidences of medullary, mucinous, papillary and tubular carcinoma were
0.51%, 1.45%, 0.71% and 0.14% of all breast cancer, respectively. There were 1 case of
local recurrence and 5 cases of systemic relapse during the follow-up (median follow-up
peroid of 56 months). Overall 5-year survival and 10-year survival rate were 98.5% and
94.2%, respectively. No significant difference in overall survival rate was detected
according to histologic types of these tumors but disease-free survival was significantly
lower in papillary carcinoma than the other types of these tumors (p=0.042). Standard
prognostic factors of breast cancer such as tumor size, lymph node status, age of the
patient and ER status did not affect the prognosis of these tumors.
Conclusion: Medullary, mucinous, papillary and tubular carcinoma revealed very
excellent prognosis in this study regardless of tumor size, lymph node status, age of the
patients and ER status.

Å°¿öµå

Breast cancer; Favorable type; Prognosis;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS